Recent Company News

• 04:15 PM ET Nov 05, 2025
  

  Transcript Intelligence: Demant Q3 Earnings Themes (DKK 226.00, 0.00)

• 04:11 PM ET Nov 05, 2025
  

  Transcript Intelligence: Demant Q3 Earnings Guidance (DKK226.00, 0.00)

• 04:10 PM ET Nov 05, 2025
  

  Transcript Intelligence: Demant Q3 Earnings Q&A (DKK226.00, 0.00)

• 11:53 AM ET Nov 04, 2025
  

  StreetAccount Metrics Recap - Demant Q3 Revenue (DKK 219.00, 0.00)

• 11:12 AM ET Nov 04, 2025
  

  Demant reports Q3 revenue DKK5.45B vs consensus DKK5.48B (DKK 219.00, 0.00)

• 05:41 AM ET Nov 03, 2025
  

  StreetAccount Consensus Metrics Preview - Demant Q3 Sales (DKK 219.00, +3.60)

• 07:44 PM ET Oct 21, 2025
  

  Demant to sell Oticon Medical to Impilo for total contractual consideration of up to DKK600M (DKK 240.80, 0.00)

• 11:55 AM ET Oct 09, 2025
  

  Demant Chair Niels Christiansen will not stand for re-election (DKK 230.20, 0.00)

• 06:48 AM ET Sep 25, 2025
  

  Trump administration initiates Section 232 investigations into medical devices and equipment, robotics and industrial machinery -- CNBC/Federal Register filings (yesterday post US-close)

• 08:07 AM ET Aug 26, 2025
  

  Lineage Cell Therapeutics announces research collaboration with William Demant Invest to develop ReSonance (ANP1) for hearing loss ($1.17, 0.00)